---
title: "BOCOM International Holdings Company Reaffirms Their Buy Rating on Gushengtang Holdings Limited (2273)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281675198.md"
description: "BOCOM International Holdings Company analyst maintained a Buy rating on Gushengtang Holdings Limited yesterday and set a price target of HK$34.20.End of Quarter Sale - 50% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Currently, the analyst consensus on Gushengtang Holdings Limited is a Strong Buy with an average price target of HK$40.11."
datetime: "2026-04-04T06:06:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281675198.md)
  - [en](https://longbridge.com/en/news/281675198.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281675198.md)
---

# BOCOM International Holdings Company Reaffirms Their Buy Rating on Gushengtang Holdings Limited (2273)

BOCOM International Holdings Company analyst maintained a Buy rating on Gushengtang Holdings Limited yesterday and set a price target of HK$34.20.

### End of Quarter Sale - 50% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Currently, the analyst consensus on Gushengtang Holdings Limited is a Strong Buy with an average price target of HK$40.11.

### Related Stocks

- [02273.HK](https://longbridge.com/en/quote/02273.HK.md)

## Related News & Research

- [Earnings Beat: Deepak Nitrite Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286980047.md)
- [Why This Analyst Thinks Texas Instruments Stock Is on the Path to $1 Trillion](https://longbridge.com/en/news/286957345.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4](https://longbridge.com/en/news/286958909.md)